Author Information
Brendan John Jenkins is a prominent researcher affiliated with the Centre for Innate Immunity and Infectious Diseases at the Hudson Institute of Medical Research, located in Clayton, Victoria, Australia. His work primarily focuses on the intricate mechanisms of innate immunity and its implications in cancer and other diseases. Jenkins's research is instrumental in understanding how immune responses are regulated and how they can be manipulated to develop novel therapeutic strategies.Research Contributions
Brendan John Jenkins has made significant contributions to the field of immunology and oncology. His recent publications, particularly from 2021 and 2022, highlight his work on the role of pattern recognition receptors in cancer, the impact of cytokines like IL-6 in pathophysiology, and the intricacies of inflammasome-associated tumorigenesis. Jenkins's research also explores the molecular mechanisms driving severe asthma, epithelial tumorigenesis, and pancreatic cancer, providing insights into potential targeted therapies and the development of patient-derived xenografts for research purposes.Aliases
Throughout his academic career, Brendan John Jenkins has been known by several aliases, including B J Jenkins, Brendan J. Jenkins, Brendan J Jenkins, Brendan John Jenkins, Brendan Jenkins, and B. Jenkins. These variations in naming are commonly used across various publications and databases.Publication and Citation Metrics
Metric |
Value |
Citation Count |
9402 |
H-index |
43 |
Paper Count |
176 |